BDBM50277889 CARFILZOMIB CHEMBL451887
- Wang, Z; Yang, J; Kirk, C; Fang, Y; Alsina, M; Badros, A; Papadopoulos, K; Wong, A; Woo, T; Bomba, D; Li, J; Infante, JR Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomib. Drug Metab Dispos 41: 230-7 (2012)
- Lee, MJ; Bhattarai, D; Yoo, J; Miller, Z; Park, JE; Lee, S; Lee, W; Driscoll, JJ; Kim, KB Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib. J Med Chem 62: 4444-4455 (2019)